3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 1
3
Phase 3
2
Phase 4
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycythemia Vera
1
Interventions
Letrozole
6
Tamoxifen
4
Cisplatin
4
Anastrozole
4
ribociclib
3
exemestane
3
Vancomycin
3
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Human Papillomavirus Recombinant Vaccine nonavalent
3
Dexamethasone
3
Carboplatin
3
Bevacizumab
3
trametinib
2
toripalimab
2
encorafenib
2
dabrafenib
2
binimetinib
2
atezolizumab
2
asciminib
2
Vincristine
2
Sodium Chloride
2
Rituximab
2
Prednisone
2
Papillomavirus Vaccines
2
Methotrexate
2
Medroxyprogesterone Acetate
2
Lenalidomide
2
Ipilimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Hydroxyurea
×
90 days
×
Clear all
NCT05853458
2026-04-30
HU-F-AIM
Novartis
Phase 4
Terminated
76 enrolled